Summary
Background. The objective of this study was to determine the importance of parental factors possibly related to dietary control in early and continuously treated patients with phenylketonuria (PKU). Methods. A questionnaire was disseminated among parents of 238 patients with PKU born after the nationwide introduction of newborn screening for PKU (1 September 1974) until 31 December 1995. The questionnaire was based on a behavioural model measuring people’s attitudes, subjective norms, and self-efficacy. Dietary control was defined on the basis of mean phenyl- alanine (Phe) concentration of the PKU patients measured between 1 January 1994 and 31 December 1996. Results. Response rate was 71%. Attitudes: children of parents who believed that their child adheres well to the diet, even if his or her Phe concentrations are sometimes too high, had lower Phe concentrations than children of parents who disagree with this statement (adjusted difference −103 μmol/L, p < 0.001). Subjective norm: Phe concentrations were higher when parents answered that their relatives did not approve when their child deviates from the diet (p = 0.004). Self-efficacy: children of parents who reported difficulties in having their child eat the synthetic protein substitute three times a day had higher Phe concentrations than those of parents who did not have such difficulties (adjusted difference 156 μmol/L, p = 0.007). Conclusion. More attention should be given to parents having their child eat the synthetic protein substitute at least three times a day and to teaching parents to keep strictly to the diet without being too rigid. These factors were strongly associated to dietary control and may be amenable to change.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ajzen I (1991) The theory of planned behavior. Organ Behav Hum Decis Process 50: 79–211.
Bandura A (1986) Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall.
Bekhof J, van Spronsen FJ, Crone MR, van Rijn M, Oudshoorn CG, Verkerk PH (2003) Influence of knowledge of the disease on metabolic control in phenylketonuria. Eur J Pediatr 162: 440–442.
Bekhof J, van Rijn M, Sauer PJ, Ten Vergert EM, Reijngoud DJ, van Spronsen FJ (2005) Plasma phenylalanine in patients with phenylketonuria self-managing their diet. Arch Dis Child 90(2): 163–164.
Brugman E, Reijneveld SA, Verhulst FC, Verloove-Vanhorick SP (2001) Identification and management of psyhosocial probelems by prevetive child health care. Arch Pediatri Adolescent Med 155: 462–468.
Hoffmann RP (2002) Adolescent adherence in type 1 diabetes. Compr Ther 28(2): 128–133.
Huijbregts SCJ, de Sonneville LMJ, Licht R, van Spronsen FJ, Verkerk PH, Sergeant JA (2002) Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia 40: 7–15.
Lanting CI, Verkerk PH (2004) Evaluation of the screening on AGS/CHT/PKU among children born in 2002 [in Dutch.] The Netherlands: TNO Prevention and Health.
MacDonald A (2000) Diet and compliance in phenylketonuria. Eur J Pediatr 159(Supplement 2): S136–S141.
MacDonald A, Rylance G, Hall SK, Asplin D, Booth IW (1996) Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet. Arch Dis Child 74: 412–417.
MacDonald A, Rylance GW, Asplin D, Hall SK, Booth IW (1998) Does a single plasma phenylalanine predict quality of control in phenylketonuria? Arch Dis Child 78: 122–126.
McQuaid EL, Nassau JH (1999) Empirically supported treatments of disease-related symptoms in pediatric psychology: asthma, diabetes, and cancer. [See comments.] J Pediatr Psychol 24: 305–328.
Prince AP, McMurray MP, Buist NR (1997) Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. J Inherit Metab Dis 20: 486–498.
Scriver CR, Kaufman S, Woo SLC (1995) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1015–1075.
Seashore MR, Wappner R, Cho S, La Cruz F (1999) Development of guidelines for treatment of children with phenylketonuria: report of a meeting at the National Institute of Child Health and Human Development held August 15, 1995, National Institutes of Health, Bethesda, Maryland. Pediatrics 104(6): e67.
Shulman S, Fish RO, Zempel CE, Gadish O, Chang P (1991) Children with phenylketonuria: the interface of family and child functioning. Dev Behav Pediatr 12: 315–321.
Smith I, Beasley M (1989) Intelligence and behaviour in children with early treated phenylketonuria. A report from the MRC/DHSS Phenylketonuria Register. Eur J Clin Nutr 43(Supplement 1): 1–5.
Smith I, Beasley MG, Wolff OH, Ades AE (1988) Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register. J Pediatr 112: 403–408.
Stemerdink BA, van der Molen MW, Kalverboer AF, et al (1999) Prefrontal lobe dysfunction in early and continuously treated phenylketonuria. Dev Neuropsychol 16: 29–57.
Stemerdink BA, Kalverboer LA, Van der Meere JJ, et al (2000) Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inherit Metab Dis 23: 548–562.
van Spronsen FJ, van Rijn M, van Dijk T, et al (1993) Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting/postprandial) in patients with phenylketonuria: effect of sample timing. Pediatrics 92: 570–573.
van Spronsen FJ, van Dijk T, Smit GP, et al (1996) Phenylketonuria: plasma phenylalanine responses to different distributions of the daily phenylalanine allowance over the day. Pediatrics 97: 839–844.
van Spronsen FJ, Smit PG, Koch R (2001) Phenylketonuria: tyrosine beyond the phenylalanine-restricted diet. J Inherit Metab Dis 24: 1–4.
Verkerk PH (1995) 20-year national screening for phenylketonuria in The Netherlands. National Guidance Commission PKU. Ned Tijdschr Geneeskd 139: 2302–2305.
Verkerk PH, van Spronsen FJ, van Houten M, Smit GPA, Sengers RCA (1994) Predictors of mean phenylalanine levels during the first five years of life in patients with phenylketonuria. Acta Paediatr Suppl 80: S70–S72.
Walter JH, White FJ (2004) Blood phenylalanine control in adolescents with phenylketonuria. Int J Adolesc Med Health 16(1): 41–45.
Weglage J, Fünders B, Schubert D, Schmidt E, Burgard P, Ullrich K (1992) Psychological and social findings in adolescents with phenylketonuria. Eur J Pediatr 151: 522–525.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Crone, M.R., van Spronsen, F.J., Oudshoorn, K. et al. Behavioural factors related to metabolic control in patients with phenylketonuria. J Inherit Metab Dis 28, 627–637 (2005). https://doi.org/10.1007/s10545-005-0014-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10545-005-0014-0